Patent details
EP4013453 Title: HYDROPHOBIC PEPTIDE SALTS FOR EXTENDED RELEASE COMPOSITIONS
Basic Information
- Publication number:
- EP4013453
- PCT Application Number:
- US2020045885
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207614595
- PCT Publication Number:
- WO2021030411
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HYDROPHOBIC PEPTIDE SALTS FOR EXTENDED RELEASE COMPOSITIONS
- French Title of Invention:
- SELS PEPTIDIQUES HYDROPHOBES POUR COMPOSITIONS À LIBÉRATION PROLONGÉE
- German Title of Invention:
- HYDROPHOBE PEPTIDSALZE FÜR ZUSAMMENSETZUNGEN MIT VERLÄNGERTER FREISETZUNG
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 02/04/2026
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 16/04/2026
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 04/03/2026
- Unitary Effect Registration Date:
- 16/04/2026
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 12/08/2020
- Grant date:
- 04/03/2026
- EP Publication Date:
- 22/06/2022
- PCT Publication Date:
- 18/02/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/03/2026
- EP B1 Publication Date:
- 04/03/2026
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/08/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 25/02/2026
- Name:
- BioMarin Pharmaceutical Inc.
- Address:
- 105 Digital Drive, Novato, CA 94949, United States (US)
Inventor
1
- Name:
- LABER, Joshua
- Address:
- United States (US)
2
- Name:
- CHOU, Tian Wei
- Address:
- United States (US)
3
- Name:
- ESTRADA, Karol
- Address:
- United States (US)
4
- Name:
- LEBOWITZ, Jonathan
- Address:
- United States (US)
5
- Name:
- ANG, JooChuan
- Address:
- United States (US)
6
- Name:
- BATTU, Sunil, Kumar
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201962885705 P
- Priority Date:
- 12/08/2019
- Priority Country:
- United States (US)
2
- Priority Number:
- 201962935052 P
- Priority Date:
- 13/11/2019
- Priority Country:
- United States (US)
3
- Priority Number:
- 202062963354 P
- Priority Date:
- 20/01/2020
- Priority Country:
- United States (US)
4
- Priority Number:
- 202062964848 P
- Priority Date:
- 23/01/2020
- Priority Country:
- United States (US)
5
- Priority Number:
- 202063038652 P
- Priority Date:
- 12/06/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 47/52; A61K 38/22; A61K 47/54; A61P 19/00; C07K 14/58; A61K 9/00; A61K 9/14;
Publication
European Patent Bulletin
1
- Issue number:
- 202610
- Publication date:
- 04/03/2026
- Description:
- Grant (B1)
2
- Issue number:
- 202619
- Publication date:
- 06/05/2026
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202621
- Publication date:
- 20/05/2026
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|